Mevinolin stimulates receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes
- PMID: 6388097
Mevinolin stimulates receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes
Abstract
The current results show that one can exploit the normal regulation of receptor synthesis to stimulate the single normal gene in FH heterozygotes to produce an increased number of LDL receptors. This stimulation can be achieved by drugs that inhibit HMG CoA reductase in the liver and by maneuvers that cause bile acid depletion. These two therapeutic approaches are most effective when they are combined. It seems reasonable to speculate that such a profound lowering of plasma cholesterol levels will minimize the development of atherosclerosis in FH heterozygotes. In a broader sense, the success of this regulatory manipulation raises the possibility that other genetic diseases may be treated through manipulation of regulatory signals that control the rates of synthesis of gene products.
Similar articles
-
Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.Proc Natl Acad Sci U S A. 1983 Jul;80(13):4124-8. doi: 10.1073/pnas.80.13.4124. Proc Natl Acad Sci U S A. 1983. PMID: 6575399 Free PMC article.
-
Regulation of LDL receptors in vivo.Agents Actions Suppl. 1984;16:191-203. doi: 10.1007/978-3-0348-7235-5_22. Agents Actions Suppl. 1984. PMID: 6592957
-
Normal cholesterol levels with lovastatin (mevinolin) therapy in a child with homozygous familial hypercholesterolemia following liver transplantation.JAMA. 1986 Nov 28;256(20):2843-8. JAMA. 1986. PMID: 3534334
-
Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs.Arteriosclerosis. 1989 Jan-Feb;9(1 Suppl):I121-34. Arteriosclerosis. 1989. PMID: 2492189 Review.
-
[LDL receptors].Rev Med Brux. 1990 Dec;11(10):481-92. Rev Med Brux. 1990. PMID: 2293288 Review. French.
Cited by
-
Comparison of plasma lipoprotein profiles and malondialdehyde between hyperlipidemia dogs with/without treatment.BMC Vet Res. 2014 Mar 14;10:67. doi: 10.1186/1746-6148-10-67. BMC Vet Res. 2014. PMID: 24625120 Free PMC article.
-
Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study.Metabolomics. 2010 Jun;6(2):191-201. doi: 10.1007/s11306-010-0207-x. Epub 2010 Apr 1. Metabolomics. 2010. PMID: 20445760 Free PMC article.
-
Lowering cholesterol, 1988. Rationale, mechanisms, and means.J Clin Invest. 1988 Jun;81(6):1653-60. doi: 10.1172/JCI113501. J Clin Invest. 1988. PMID: 3290249 Free PMC article. Review. No abstract available.
-
Prospects of statins in Parkinson disease.Neuroscientist. 2011 Jun;17(3):244-55. doi: 10.1177/1073858410385006. Epub 2011 Jan 20. Neuroscientist. 2011. PMID: 21252380 Free PMC article. Review.
-
An overview of lipid-lowering drugs.Drugs. 1988;36 Suppl 3:63-71. doi: 10.2165/00003495-198800363-00015. Drugs. 1988. PMID: 3076124 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Miscellaneous